Dujuan Lu - uventia

Dujuan Lu

Dujuan Lu

Dujuan Lu

E&L Manager/Global Leader

SGS-Health-Science

Dr. Dujuan Lu serves as the manager for the extractables and leachables (E&L) team at the SGS Health Science Fairfield New Jersey USA facility as well as the global leader amongst the global E&L centers of excellence. Dr. Lu obtained her PhD in analytical chemistry from the University of Pittsburgh and has extensive CRO and pharmaceutical/medical device industry experience with more than 500 E&L projects. She was named one of the top 60 most influential people working in the pharmaceutical industry in the Medicine Maker’s 2020 power list.

SPEAKED ABOUT:
4th Annual Extractables & Leachables
March 7, 2024
What is next in testing and analyzing for extractables and leachables in biopharmaceutical development and release? Recording of 2 days event sessions [18 video sessions].
Expired

DAY 2: MARCH 8th, 2024

SESSION: A simultaneous UHPLC-UV-CAD-HRMS multi-detector platform for comprehensive extractables and leachables analysis of pharmaceutical packaging and medical device materials

◆  We will demonstrate the combination of the three detection techniques in one system to allow the concurrent measurement of UV absorption, Charged Aerosol Detection (CAD) signal and high resolution-accurate mass (HRAM) mass spectra from one injection.

◆  The inclusion of CAD detection provides complementary information to UV and HRMS, enabling more reliable semi-quantitation of non-chromophoric and non-volatile compounds.

◆  Several case studies will be shown with the application of this multi-detector approach in extractable studies of pharmaceutical packaging and medical device components.

3rd Annual Extractables & Leachables
March 9, 2023
Learn innovative techniques for analyzing and testing for extractables and leachables in biopharmaceutical development. Recording of 2 days event sessions [20 video sessions].
Expired

DAY 2: MARCH 10th, 2023

SESSION: Analytical considerations in extractables and leachables testing of drug-device combination products

◆  Regulatory & industry guidance to follow for E&L study design of Drug-Device Combination Products.

◆  Difference & Similarity on E&L requirements between pharmaceutical products and medical devices.

◆  (USP <1663> vs. ISO 10993-18).

◆  Case studies on E&L Testing of combination products.

Speaker Details
Speaker Details